Latest Market News

PYC Therapeutics reports sustained vision improvements in patients with Retinitis Pigmentosa type 11 treated with VP-001, showing promising safety and efficacy up to 18 months. The company plans to engage the FDA in early 2026 to finalize pivotal trial design.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Synlait Milk Limited has temporarily expanded its banking facilities by NZ$50 million to manage ongoing cost impacts from earlier manufacturing challenges, while preparing to reduce debt through a major asset sale.

Alkane Resources reports a strong first quarter for FY2026, driven by its recent acquisition of Mandalay Resources, boosting gold equivalent production and revenue significantly.

Alkane Resources reports its Q1 FY2026 interim results, highlighting the integration of Mandalay Resources and key operational developments across its global mining portfolio.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

Nimy Resources announces a maiden JORC Inferred Mineral Resource at its Mons Block 3 project in Western Australia, featuring exceptionally high-grade gallium and significant rare earth oxides, positioning the company as a potential key supplier amid global supply constraints.

The Supreme Court of Western Australia has approved the share and option schemes for Capricorn Metals’ acquisition of Warriedar Resources, setting the stage for a significant consolidation in the gold exploration sector.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.

Tombador Iron Limited has completed its strategic acquisition of GoviEx Uranium Inc., paving the way for a relisting as Atomic Eagle Ltd focused on uranium exploration.

Sequoia Financial Group’s subsidiary InterPrac Financial Planning faces ASIC civil penalty proceedings over past investment advice but plans a robust defence.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.